Pharmacological IRS1/2 Inhibition Reduces Cell Viability in BCR-ABL1 Positive Cells

被引：0

作者：

Scopim-Ribeiro, Renata ^{[1
]}

Machado-Neto, Joao Agostinho ^{[1
]}

Campos, Paula de Melo ^{[2
]}

Santos Duarte, Adriana da Silva ^{[2
]}

Scheucher, Priscila Santos ^{[1
]}

Goes, Amelia ^{[1
]}

Olalla Saad, Sara Teresinha ^{[2
]}

Simoes, Belinda Pinto ^{[1
]}

Rego, Eduardo Magalhaes ^{[1
]}

Traina, Fabiola ^{[1
]}

机构：

[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, BR-14049 Ribeirao Preto, Brazil

[2] Univ Estadual Campinas, Inst Nacl Ciencia & Tecnol Sangue, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Co-occurrence of BCR-ABL1 rearrangement and CALR mutation in a single leukemic stem cell: evidence that BCR-ABL1 oncogenic addiction prevails over CALR signaling
Balducci, Estelle
Sanekli, Safa
Hugues, Patricia
Soubeyrand, Mathis
Borie, Claire
Fund, Xavier
Desterke, Christophe
Aumont, Cedric
Faivre, Jamila
Bennaceur-Griscelli, Annelise
Turhan, Ali G.
LEUKEMIA & LYMPHOMA, 2020, 61 (01) : 209 - 212
[42] Bone marrow histopathology in accelerated phase of BCR-ABL1 positive chronic myeloid leukemia
Murari, M.
Sharma, S.
VIRCHOWS ARCHIV, 2019, 475 : S117 - S117
[43] DIAGNOSIS AND MONITORING OF INDIAN COHORT OF CHRONIC MYELOID LEUKAEMIA, BCR-ABL1 POSITIVE PATIENTS
Joshi, Swapnali
Chaudhary, Shruti
Mehta, Arpan
Mascarenhas, Russel
Subramanian, P. G.
Tembhare, Prashant
Gujral, Sumeet
Patkar, Nikhil
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 : 65 - 65
[44] IMATINIB INDUCES MARKED UPREGULATION OF RECOMBINATION ACTIVATING GENE (RAG) EXPRESSION IN BCR-ABL1 POSITIVE LYMPHOID CELLS
Shahrin, Nur Hezrin
Thomson, Daniel
Wadham, Carol
Schreiber, Andreas
Branford, Susan
EXPERIMENTAL HEMATOLOGY, 2019, 76 : S85 - S85
[45] Clinical implications of cytogenetic heterogeneities in BCR-ABL1 fusion positive adult B cell acute lymphoblastic leukemia
Lu, Xinyan
CANCER GENETICS, 2018, 224 : 53 - 53
[46] IGF1R/IRS PHARMACOLOGICAL INHIBITION REDUCES CELL PROLIFERATION AND MIGRATION IN ACUTE LYMPHOBLASTIC LEUKEMIA CELLS
Rodrigues Alves, A. P. N.
Machado-Neto, J.
Scopim-Ribeiro, R.
Fernandes, J. C.
Fenerich, B. A.
Da Silva, F. B.
Scheucher, P. S.
Simoes, B. P.
Rego, E. M.
Ridley, A. J.
Traina, F.
HAEMATOLOGICA, 2017, 102 : 343 - 343
[47] Clinical Implications of Cytogenetic Heterogeneity in BCR-ABL1 Fusion Positive Adult B Cell Acute Lymphoblastic Leukemia
Lu, X.
Medeiros, L. J.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S6 - S6
[48] Evolution of Human BCR-ABL1 lymphoblastic Leukaemia-Initiating Cells.
Notta, Faiyaz
Mullighan, Charles
Wang, Jean
Poeppl, Armando G.
Doulatov, Sergei
Phillips, Letha A.
Ma, Jing
Minden, Mark D.
Downing, James R.
Dick, John E.
BLOOD, 2010, 116 (21) : 451 - 451
[49] Interference of BCR-ABL1 kinase activity with antigen receptor signaling in B cell precursor leukemia cells
Klein, F
Feldhahn, N
Müschen, M
CELL CYCLE, 2004, 3 (07) : 858 - 860
[50] Development of Synthetic Secondary Standards for BCR-ABL1 Quantification on GeneXpert BCR-ABL V2 and Xpert BCR-ABL Ultra Assays
Mihani, R.
Rundell, C.
Gordon, J.
Nesbitt, S.
Spenlinhauer, T.
Nguyen, T.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 929 - 929

← 1 2 3 4 5 →